Independence Holding: stocks, financial statements

Dividends News
Favorites

Independence Holding Co. engages in underwriting, administering and distributing group & individual specialty products, including disability, supplemental health, pet, and group life insurance through its subsidiaries. It operates through the following segments: Medical Stop-Loss, Specialty Health, Group Disability, and Individual Accident and Health, and Other. The Medical Stop-Loss segment are short-duration and accounted for based on actuarial estimates of the amount of loss inherent in that period's claims or open claims for prior periods, including losses incurred for claims that have not been reported. The Specialty Health segment is the liability for policy benefits and claims for fully insured medical and dental business and are established using historical claim development patterns. The Group Disability segment is comprised of long term disability and disability benefits law. The Individual Accident and Health and Other segment is a combination of closed lines of business as well as certain small existing lines. The company was founded in 1980 and is headquartered in Stamford, CT.

  • IHC Ticker
  • NYSE Exchange
  • Employees
2 rated
  • $42.77, $-0.41 (-0.95%) Previous Close
  • 19,903 Previous Volume
  • $26.19 / $48.26 52 week low / high
  • -10.53% Percent off 52 week high
  • 2021-06-18 Updated
  • 1.03% Dividend Yield (trailing)
  • 1.03% Dividend Yield (forward)
  • 0 Public float
  • 14,658,969 Outstanding shares
  • 31.30 P/E
  • 632.97 M Market Cap
Disable ads for free

Financial statements — Independence Holding

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
20 ← 16 2020 2019 2018 2017 2016
Total Revenue
440M 370M 350M 320M 310M
Cost Of Revenue
0 0 0 0 0
Gross Profit
440M 370M 350M 320M 310M
Research and Development
0 0 0 0 0
Selling General and Admin
210M 170M 170M 160M 130M
Operating Expense
410M 350M 310M 290M 280M
Operating Income
30M 25M 38M 28M 32M
Other Income Expense Net
0 0 0 0 0
EBIT
30M 25M 38M 28M 32M
Interest Income
0 0 0 0 0
Pretax Income
30M 25M 38M 28M 32M
Income Tax
11M 13M 8.5M -14M 9.6M
Minority Interest
240K 290K 570K 88K 10M
Net Income
19M 12M 28M 42M 120M
Net Income Basic
19M 12M 28M 42M 120M
20 ← 16 2020 2019 2018 2017 2016
Current cash
0 0 0 0 0
Short term investments
470M 500M 470M 470M 510M
Receivables
390M 390M 390M 400M 480M
Inventory
0 0 0 0 0
Other current assets
0 0 0 11M 18M
Current assets
930M 910M 890M 900M 1B
Long term investments
150M 140M 150M 140M 120M
Property plant equipment
0 0 0 0 0
Goodwill
75M 60M 51M 51M 42M
Intangible assets
0 0 0 0 0
Other assets
76M 73M 83M 73M 55M
Total assets
1.1B 1.1B 1B 1B 1.1B
Accounts payable
0 0 0 0 0
Current long term debt
0 0 0 0 0
Other current liabilities
610M 590M 580M 600M 700M
Total current liabilities
610M 590M 580M 600M 700M
Long term debt
0 0 0 0 0
Other liabilities
0 0 0 0 0
Minority Interest
2.4M 2.3M 4.9M 4.8M 2.7M
Total Liabilities
610M 590M 590M 610M 700M
Common stock
15M 15M 15M 16M 17M
Retained earning
400M 390M 380M 360M 320M
Treasury stock
-77M -70M -66M -63M -17M
Capital surplus
Shareholder equity
470M 460M 450M 430M 440M
Net tangible assets
390M 400M 400M 380M 390M
20 ← 16 2020 2019 2018 2017 2016
Net Income
19M 12M 28M 42M 120M
Depreciation
4.6M 3.2M 2.9M 1.9M 1.8M
Changes in receivables
-2.8M -3.9M -9.4M -81M -67M
Changes in inventories
0 0 0 0 0
Cash change
51M -5.1M -290K 4.5M 2.8M
Cash flow
51M 39M 36M 29M -31M
Capital expenditures
0 0 0 0 0
Investments
Investing activity other
Total investing cash flows
13M -27M -28M 28M 99M
Dividends paid
Net borrowings
-470M -500M -470M -470M -510M
Other financing cash flows
Cash flow financing
-14M -18M -9.7M -52M -65M
Exchange rate effect